StopDown
Funding · 7 April 2026BioPrime$6 MnBiological agri inputs for crop resilience

BioPrime raises $6 million Series A from Edaphon

By · Editor ·

Series APuneFounded 2016
  • BioPrime makes biological sprays and soil additives that help crops withstand climate stress
  • It raised a $6 Mn Series A led by Belgium-based Edaphon, with Omnivore and Inflexor Ventures
  • The company has grown revenue three-fold year-on-year and plans to become profitable next year

What happened

  • BioPrime is a Pune-based startup that builds biological agricultural inputs.
  • It uses biochemicals and microbes to help crops withstand climatic stress, improve yield quality and soil health.
  • The company has raised a $6 Mn Series A round led by Belgium-based Edaphon.
  • Existing investors Omnivore and Inflexor Ventures also participated in the round.
  • BioPrime has raised a total of $8 Mn to date.
  • The company has achieved three-fold year-on-year revenue growth.
  • It plans to become profitable next year and focus on international expansion.

Why it matters

  • India's biofertiliser market is projected to grow from $165.93 Mn to $253.09 Mn by 2031.
  • The biostimulants market is expected to reach $365.38 Mn by 2031 from $230.68 Mn.
  • Growth drivers include policy support, rising fertiliser costs, and global demand for residue-free produce.
  • BioPrime's technology primes crops in advance using secondary metabolites (alkaloids, terpenes, etc.).

The business

  • BioPrime builds biological agri inputs such as sprays and irrigation additives.
  • Its patented tech stack includes SNIPR (biomolecules) for immediate protection and BioNexus (microbes) for long-term soil health.
  • Products include soil restoration inputs, bio-insecticides, and bio-fungicides.
  • The company works with secondary metabolites (alkaloids, terpenes, amines, etc.) to prime crops in advance.
  • It has tied up with Yara, ICL Fertilizers, DCM Shriram, and Insecticides India.
  • BioPrime uses a 'seeing is believing' adoption strategy with demo farms and side-by-side yield calculations.

The founders

Dr Renuka Diwan

Cofounder
  • Background in academia and genetic engineering.
  • Cofounder of BioPrime.

Dr Amit Shinde

Cofounder
  • Background in industrial R&D at Kumar Florist.
  • Cofounder of BioPrime.

Dr Shekhar Bhosle

Cofounder
  • Background in startup ecosystem.
  • Cofounder of BioPrime.

Who put in money

  • Edaphon lead — Belgium-based investor.
  • Omnivore participated — Existing investor.
  • Inflexor Ventures participated — Existing investor.

In numbers

$8 MnTotal raised · 2026
$6 MnSeries A amount · 2026
three-fold year-on-yearRevenue growth · 2026
$165.93 MnIndia biofertiliser market size · 2026
$253.09 MnIndia biofertiliser market projection · 2031
$230.68 MnIndia biostimulants market size · 2026
$365.38 MnIndia biostimulants market projection · 2031

What happens next

  • BioPrime plans to become profitable next year.
  • It will focus on international expansion, particularly in the US, Brazil, and Southeast Asia.

Words to know

Secondary metabolites
Organic compounds produced by plants that are not directly involved in growth but help in defence and stress response (e.g., alkaloids, terpenes).
Biofertiliser
A substance containing living microorganisms that enrich soil nutrients when applied to crops.
Biostimulant
A substance that enhances plant growth and stress tolerance without being a fertiliser or pesticide.
Series A
The first significant venture capital funding round after seed stage, used to scale operations.

The numbers around it

Agriculture & Food Systems in April 2026: 4 rounds with a disclosed amount, $15.9 million in all; the biggest was BioPrime ($6 Mn). Every sector this year →

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
  • Profitability: A path to profitability is the plan and evidence that a startup will earn more than it spends. In India the usual order is contribution positive, then EBITDA positive, then net profit and positive cash flow. Each step is a different test, so claims of profit need the definition.
  • Profitability: Profitable can mean five different things in a startup headline: profit after tax, positive EBITDA, positive adjusted EBITDA, positive cash flow or profit on each order. Only the first is a profit in the full accounting sense. Always check which one a story means.

Everything on BioPrime → · All startup news on 7 April 2026 →

Is this BioPrime? Get your “Featured on StopDown” badge →